Ian Mak

743 total citations
11 papers, 591 citations indexed

About

Ian Mak is a scholar working on Pulmonary and Respiratory Medicine, Hematology and Immunology. According to data from OpenAlex, Ian Mak has authored 11 papers receiving a total of 591 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pulmonary and Respiratory Medicine, 4 papers in Hematology and 4 papers in Immunology. Recurrent topics in Ian Mak's work include Renal cell carcinoma treatment (4 papers), Reproductive System and Pregnancy (4 papers) and Multiple Myeloma Research and Treatments (4 papers). Ian Mak is often cited by papers focused on Renal cell carcinoma treatment (4 papers), Reproductive System and Pregnancy (4 papers) and Multiple Myeloma Research and Treatments (4 papers). Ian Mak collaborates with scholars based in United Kingdom, Singapore and Canada. Ian Mak's co-authors include L Pyle, Tim Eisen, Roger A’Hern, Martin Gore, Francisco Sapunar, Jan J. Brosens, Mark Christian, J.O. White, Chris Boshoff and Matthew Vaughan and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Endocrinology.

In The Last Decade

Ian Mak

10 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian Mak United Kingdom 9 230 179 178 154 147 11 591
Volker Moebus Germany 15 164 0.7× 51 0.3× 95 0.5× 144 0.9× 393 2.7× 52 705
M. R. Sertoli Italy 11 141 0.6× 185 1.0× 98 0.6× 87 0.6× 391 2.7× 26 638
Taren Johnston United States 7 264 1.1× 35 0.2× 161 0.9× 199 1.3× 120 0.8× 9 638
U. Matulonis United States 9 125 0.5× 126 0.7× 43 0.2× 122 0.8× 342 2.3× 33 596
J A Katzmann United States 9 156 0.7× 72 0.4× 298 1.7× 110 0.7× 153 1.0× 20 592
Remedios Castelló Spain 14 161 0.7× 105 0.6× 110 0.6× 196 1.3× 58 0.4× 14 638
A.B.W. Nethersell United Kingdom 14 117 0.5× 99 0.6× 70 0.4× 45 0.3× 157 1.1× 30 523
Mitsuyo Yoshihara Japan 18 341 1.5× 81 0.5× 47 0.3× 57 0.4× 295 2.0× 37 868
Alejandro Rojo‐Sebastián Spain 14 375 1.6× 116 0.6× 19 0.1× 142 0.9× 122 0.8× 18 686
Fumio Kataoka Japan 16 268 1.2× 55 0.3× 26 0.1× 312 2.0× 248 1.7× 54 814

Countries citing papers authored by Ian Mak

Since Specialization
Citations

This map shows the geographic impact of Ian Mak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Mak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Mak more than expected).

Fields of papers citing papers by Ian Mak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Mak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Mak. The network helps show where Ian Mak may publish in the future.

Co-authorship network of co-authors of Ian Mak

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Mak. A scholar is included among the top collaborators of Ian Mak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Mak. Ian Mak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
2.
Mak, Ian, Edmond Lou, James Raso, et al.. (2008). The effect of time on qualitative compliance in brace treatment for AIS. Prosthetics and Orthotics International. 32(2). 136–144. 15 indexed citations
3.
Patel, Poulam M., Peter J. Selby, Barry W. Hancock, et al.. (2006). Randomized Phase II Study Comparing Thalidomide With Medroxyprogesterone Acetate in Patients With Metastatic Renal Cell Carcinoma. Journal of Clinical Oncology. 24(6). 898–903. 16 indexed citations
4.
Mak, Ian, Jan J. Brosens, Mark Christian, et al.. (2002). Regulated Expression of Signal Transducer and Activator of Transcription, Stat5, and its Enhancement of PRL Expression in Human Endometrial Stromal Cells in Vitro. The Journal of Clinical Endocrinology & Metabolism. 87(6). 2581–2588. 72 indexed citations
5.
Christian, Mark, Ian Mak, J.O. White, & Jan J. Brosens. (2002). Mechanisms of decidualization. Reproductive BioMedicine Online. 4. 24–30. 33 indexed citations
6.
Mak, Ian, Stephan Gordts, Rudi Campo, et al.. (2002). Aromatase P450 messenger RNA expression in eutopic endometrium is not a specific marker for pelvic endometriosis. Fertility and Sterility. 78(4). 825–829. 36 indexed citations
7.
Christian, Mark, Petros Marangos, Ian Mak, et al.. (2001). Interferon-γ Modulates Prolactin and Tissue Factor Expression in Differentiating Human Endometrial Stromal Cells1. Endocrinology. 142(7). 3142–3151. 47 indexed citations
8.
Stebbing, Justin, Charlotte Benson, Timothy Eisen, et al.. (2001). The treatment of advanced renal cell cancer with high-dose oral thalidomide. British Journal of Cancer. 85(7). 953–958. 8 indexed citations
9.
Stebbing, Justin, Charlotte Benson, Tim Eisen, et al.. (2001). The treatment of advanced renal cell cancer with high-dose oral thalidomide. British Journal of Cancer. 85(7). 953–958. 89 indexed citations
10.
Eisen, Tim, Chris Boshoff, Ian Mak, et al.. (2000). Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer. British Journal of Cancer. 82(4). 812–817. 274 indexed citations
11.
Eisen, Tim, Chris Boshoff, Ian Mak, et al.. (1999). A PHASE II STUDY OF CONTINUOUS LOW DOSE THALIDOMIDE IN PATIENTS WITH RENAL CELL. MELANOMA, OVARIAN AND BREAST CANCER. Journal of Immunotherapy. 22(5). 458–458. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026